D. E. Shaw Venture Capital

D. E. Shaw Venture Capital, also known as D. E. Shaw Ventures, is the venture capital and private equity investment arm of the D. E. Shaw Group, a global investment and technology development firm. The unit specializes in early- to late-stage investments in technology-oriented companies, with a significant focus on the life sciences, biotechnology, and healthcare sectors. Leveraging the broader group's expertise in computational science and quantitative analysis, D. E. Shaw Venture Capital identifies and supports companies developing disruptive technologies, including drug discovery platforms, medical devices, and healthcare IT. While it operates as an investment entity, it is part of a scientific ecosystem that includes D. E. Shaw Research (DESRES), a separate biochemistry research company that conducts independent drug discovery. Notable life science investments in its portfolio include Roivant Sciences, Relay Therapeutics, and Natrix Separations.